Two common misconceptions about multiple sclerosis (MS) are that the disease of the central nervous system affects everyone the same way; and that being diagnosed with the condition guarantees ...

PPMS is a less common form of MS characterized by a gradual worsening of symptoms from the onset, whereas RRMS involves distinct relapses followed by periods of remission. PPMS is typically diagnosed ...

Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus)treats ...

Now this could explain why the beta-interferon drug used to treat multiple sclerosis patients only works in half of them. Plus a third of them endure flu-like symptoms from the treatment. There are ...

McArdle sign is related to a diagnosis of MS; however, this sign has been described only twice previously. When defined as a reduction in neck strength >10% with neck flexion, McArdle sign is 100% ...